12 including Prof Ananthamurthy, Kinhanna Rai bag state awards

Udupi, May 12: The Coastal Bus Owner’s Association members have approached Deputy Commissioner to permit them to run bus service in the District.

Nearly 80 buses coming under the Coastal Bus Association and they are prepared to run the buses as per the guidelines set by the government. They have also requested RTO officials for permission to operate and are awaiting approval. If the bus service starts operating, many workers like drivers, conductors, cleaners, mechanics will get employment.

Coastal Bus Owners Association President Raghavendra Bhat said that the bus owners must provide services to the public as per regulations set by Deputy Commissioner.

Udupi, Jun 16: A young software engineer died on board a bus bound for Udupi’s Kundapura from Bengaluru due to suspected cardiac arrest this morning.

The deceased has been identified as Chaitanya (25), son of Vishnu Murthy, a resident of Kumbri in Koteshwar in Kundapura taluk. He was working for a software firm Bengaluru.

Chaitanya had boarded a ‘Durgamba’ bus from Bengaluru at 9 pm on June 15. At around 6.30 am on June 16, he called his father and informed that the bus had reached Barkur.

When his father called Chaitanya again at around 7.30 am, the bus driver answered the call and told him that his son had fallen ill and been taken to Vinaya hospital in Kundapur.

Vishnu Murthy rushed to the hospital, but was informed by the doctors that Chaitanya was declared brought dead.

A case has been registered at Kundapura police station. Even though it is suspected that he died of cardiac arrest, the exact cause will be known only after the post-mortem.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.